Y. Yataghene

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

T. Conroy, M. Ychou, M. Ducreux, 2008, British Journal of Cancer.

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

P. Soulié, E. Brain, J. Misset, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Relation between long-term blood pharmacokinetics (PK), pharmacogenomics (PG), and severe neurotoxicity in patients undergoing an oxaliplatin (O)-based regimen.

M. Hebbar, F. Bonnetain, A. de Gramont, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Percutaneous antegrade dilation of ureteral strictures in kidney transplants.

B. Charpentier, G. Benôit, A. Jardin, 1993, The Journal of urology.

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

E. Raymond, P. Hérait, G. Deplanque, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

T. Conroy, D. Peiffert, L. Mineur, 2010, British Journal of Cancer.

Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

E. Raymond, P. Hérait, G. Deplanque, 2012 .

Percutaneous antegrade dilatation of ureteral strictures in kidney transplants.

B. Charpentier, G. Benôit, A. Jardin, 1994, Transplantation proceedings.

An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

S. Culine, J. Trédaniel, J. Alexandre, 2009, Lung cancer.